BMC Psychol. 2025 Aug 19;13(1):940. doi: 10.1186/s40359-025-03278-8.
NO ABSTRACT
PMID:40830507 | DOI:10.1186/s40359-025-03278-8
Recent Posts
- Novel Azepinoindoles as 5-HT2C Agonists for Treating Depression, Drug Addiction, Alcoholism, PTSD, and Neuropathic Pain
- Novel Non-hallucinogenic Neurite Growth Compounds as 5-HT2A Agonists for Treating Stress-Related Disorders, Namely Depression, Anxiety, and PTSD
- Novel 3-(2-(Aminoethyl)-indol-4-ol Derivatives as 5-HT2C Agonists for Treating Depression, Alcoholism, Drug Addiction, PTSD, and Seizure Disorders
- Proline Homologation in Melanostatin Neuropeptide: Discovery of Potent Modulators of the Dopamine D2 Receptors
- Multi-target approach of Egyptian leek extract in ameliorating depressive-like behavior in rats exposed to chronic unpredictable mild stress
Recent Comments